Quick Answer
PLIANT THERAPEUTICS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2025.
- This data is from PLIANT THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $28.94 million | Q2 2020: $3.60 million | Q3 2020: $4.81 million | Q1 2021: $2.17 million | Q2 2021: $1.79 million | Q3 2021: $1.61 million | Q1 2022: $1.25 million | Q2 2022: $4.99 million | Q3 2022: $1.48 million | Q1 2023: $1.33 million | Q2 2023: $248.0 thousand | Q3 2023: $0.00 | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00.
- Over the full 7 years of available data (2019 to 2025), PLIANT THERAPEUTICS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $1.58 million | Fiscal year 2022: $9.69 million | Fiscal year 2021: $7.57 million | Fiscal year 2020: $41.82 million | Fiscal year 2019: $57.05 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: